Discounted Cash Flow
Guardant Health, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $313.2k | $-410.4k | $-1.8m | -131.0% | $-0.15 |
| 2017 | $49.8m (15812.3%) | $-83.2m (-20175.9%) | $-78.9m (-4271.4%) | -167.0% (-27.4%) | — |
| 2018 | $90.6m (81.9%) | $-85.1m (-2.2%) | $-92.4m (-17.1%) | -93.8% (43.8%) | — |
| 2019 | $214.4m (136.5%) | $-75.7m (11.1%) | $-65.9m (28.7%) | -35.3% (62.4%) | $-0.84 |
| 2020 | $286.7m (33.8%) | $-246.3m (-225.6%) | $-140.1m (-112.8%) | -85.9% (-143.4%) | $-2.60 (-209.5%) |
| 2021 | $373.7m (30.3%) | $-384.8m (-56.2%) | $-284.1m (-102.7%) | -103.0% (-19.9%) | $-4.00 (-53.8%) |
| 2022 | $449.5m (20.3%) | $-654.6m (-70.1%) | $-386.9m (-36.2%) | -145.6% (-41.4%) | $-6.41 (-60.2%) |
| 2023 | $563.9m (25.5%) | $-479.4m (26.8%) | $-345.5m (10.7%) | -85.0% (41.6%) | $-4.28 (33.2%) |
| 2024 | $739.0m (31.0%) | $-436.4m (9.0%) | $-274.9m (20.4%) | -59.0% (30.5%) | $-3.56 (16.8%) |
| 2025 | $982.0m (32.9%) | $-416.3m (4.6%) | $-233.1m (15.2%) | -42.4% (28.2%) | $-3.32 (6.7%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.